{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-012804","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.472724+00:00","generated_at":"2026-05-17T07:42:02.543848+00:00","sec_items":["1.01","3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Immix Biopharma raises $9.1M in PIPE; Nancy Chang appointed to board","bullets":["Sold 3,831,216 shares at $2.37/share and warrants for 2,873,417 shares at $2.00/share.","Gross proceeds ~$9.1M for working capital and general corporate purposes; closed on Sept 5, 2025.","Warrants are non-transferable, exercisable for 10 years, and only for cash.","Nancy Chang, Ph.D. appointed to board effective Sept 8, 2025; co-founded Tanox (XOLAIR developer).","Resale registration statement to be filed with SEC within 30 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-012804","json":"https://secwatch.observer/filing/0001493152-25-012804.json","markdown":"https://secwatch.observer/filing/0001493152-25-012804.md","text":"https://secwatch.observer/filing/0001493152-25-012804.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/0001493152-25-012804-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:42:02.543848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}